Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_VERTEBCOLLAPSE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.69 [0.42-1.14],0.14974132578982,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_VERTEBCOLLAPSE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.61 [0.5-5.19],0.422209692553545,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_VERTEBCOLLAPSE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.13 [0.28-4.49],0.864431284891236,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_VERTEBCOLLAPSE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,3.49 [0.57-21.28],0.175988774158308,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_VERTEBCOLLAPSE,GDF15,Growth/differentiation factor 15,Wald ratio,1,3.01 [0.01-1140.25],0.715962716060247,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_VERTEBCOLLAPSE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.23 [0.19-7.84],0.830127413417323,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_VERTEBCOLLAPSE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.18 [0.14-10.21],0.877557655115714,trans
